Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8882 |
High Similarity |
NPD7685 |
Pre-registration |
0.8514 |
High Similarity |
NPD7266 |
Discontinued |
0.8442 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7803 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7651 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7602 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7561 |
Intermediate Similarity |
NPD37 |
Approved |
0.756 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7558 |
Intermediate Similarity |
NPD7472 |
Approved |
0.755 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7544 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.753 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.753 |
Intermediate Similarity |
NPD4966 |
Approved |
0.753 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7516 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7483 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7468 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7457 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7456 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7452 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7452 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7429 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7397 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7383 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7333 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.733 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7314 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.729 |
Intermediate Similarity |
NPD1613 |
Approved |
0.729 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7219 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7176 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD228 |
Approved |
0.7079 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD6362 |
Approved |
0.7044 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7041 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7037 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7032 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7025 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7025 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7025 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7019 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7019 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7019 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7 |
Intermediate Similarity |
NPD8313 |
Approved |
0.6995 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6994 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6994 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6962 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6959 |
Remote Similarity |
NPD3817 |
Phase 2 |
0.6948 |
Remote Similarity |
NPD3094 |
Phase 2 |
0.6932 |
Remote Similarity |
NPD6166 |
Phase 2 |
0.6932 |
Remote Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.6932 |
Remote Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD1358 |
Approved |
0.6919 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6913 |
Remote Similarity |
NPD5536 |
Phase 2 |
0.6911 |
Remote Similarity |
NPD7680 |
Approved |
0.691 |
Remote Similarity |
NPD5844 |
Phase 1 |
0.691 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD5058 |
Phase 3 |
0.6903 |
Remote Similarity |
NPD5647 |
Approved |
0.6901 |
Remote Similarity |
NPD2801 |
Approved |
0.6901 |
Remote Similarity |
NPD2978 |
Approved |
0.6901 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.6901 |
Remote Similarity |
NPD2977 |
Approved |
0.689 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.689 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6886 |
Remote Similarity |
NPD6273 |
Approved |
0.6886 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6879 |
Remote Similarity |
NPD7095 |
Approved |
0.6871 |
Remote Similarity |
NPD5283 |
Phase 1 |
0.6868 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6859 |
Remote Similarity |
NPD9494 |
Approved |
0.6859 |
Remote Similarity |
NPD5736 |
Approved |
0.6853 |
Remote Similarity |
NPD3134 |
Approved |
0.6851 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6848 |
Remote Similarity |
NPD6842 |
Approved |
0.6848 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6848 |
Remote Similarity |
NPD6841 |
Approved |
0.6833 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6821 |
Remote Similarity |
NPD3882 |
Suspended |
0.6813 |
Remote Similarity |
NPD4340 |
Discontinued |
0.681 |
Remote Similarity |
NPD1375 |
Discontinued |
0.6805 |
Remote Similarity |
NPD3686 |
Approved |
0.6805 |
Remote Similarity |
NPD3687 |
Approved |
0.6802 |
Remote Similarity |
NPD1465 |
Phase 2 |
0.6798 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6797 |
Remote Similarity |
NPD422 |
Phase 1 |
0.679 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6782 |
Remote Similarity |
NPD7075 |
Discontinued |
0.6779 |
Remote Similarity |
NPD7157 |
Approved |
0.677 |
Remote Similarity |
NPD6353 |
Approved |
0.6763 |
Remote Similarity |
NPD5353 |
Approved |
0.6732 |
Remote Similarity |
NPD3496 |
Discontinued |
0.673 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6726 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6723 |
Remote Similarity |
NPD6232 |
Discontinued |
0.671 |
Remote Similarity |
NPD2982 |
Phase 2 |
0.671 |
Remote Similarity |
NPD5327 |
Phase 3 |
0.671 |
Remote Similarity |
NPD2983 |
Phase 2 |
0.6709 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6708 |
Remote Similarity |
NPD1933 |
Approved |
0.6708 |
Remote Similarity |
NPD447 |
Suspended |
0.6708 |
Remote Similarity |
NPD3657 |
Discovery |
0.6689 |
Remote Similarity |
NPD7843 |
Approved |
0.6688 |
Remote Similarity |
NPD4624 |
Approved |
0.6688 |
Remote Similarity |
NPD3092 |
Approved |
0.6687 |
Remote Similarity |
NPD6663 |
Approved |
0.6687 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6687 |
Remote Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.6686 |
Remote Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD1511 |
Approved |
0.6667 |
Remote Similarity |
NPD2492 |
Phase 1 |
0.6667 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6667 |
Remote Similarity |
NPD4626 |
Approved |
0.6667 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6667 |
Remote Similarity |
NPD5402 |
Approved |
0.6667 |
Remote Similarity |
NPD3751 |
Discontinued |
0.6667 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6646 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.6645 |
Remote Similarity |
NPD2981 |
Phase 2 |
0.6627 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.6627 |
Remote Similarity |
NPD4236 |
Phase 3 |
0.6627 |
Remote Similarity |
NPD4237 |
Approved |
0.6626 |
Remote Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.6625 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6622 |
Remote Similarity |
NPD969 |
Suspended |
0.661 |
Remote Similarity |
NPD5494 |
Approved |
0.6609 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6609 |
Remote Similarity |
NPD7819 |
Suspended |
0.6609 |
Remote Similarity |
NPD5563 |
Clinical (unspecified phase) |
0.6603 |
Remote Similarity |
NPD4749 |
Approved |
0.6601 |
Remote Similarity |
NPD5691 |
Approved |
0.6599 |
Remote Similarity |
NPD3021 |
Approved |
0.6599 |
Remote Similarity |
NPD3022 |
Approved |
0.659 |
Remote Similarity |
NPD6385 |
Approved |
0.659 |
Remote Similarity |
NPD6386 |
Approved |
0.6588 |
Remote Similarity |
NPD1512 |
Approved |
0.6587 |
Remote Similarity |
NPD7982 |
Clinical (unspecified phase) |
0.6587 |
Remote Similarity |
NPD6331 |
Phase 2 |
0.6585 |
Remote Similarity |
NPD4108 |
Discontinued |
0.6582 |
Remote Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.6581 |
Remote Similarity |
NPD1610 |
Phase 2 |
0.6575 |
Remote Similarity |
NPD7799 |
Discontinued |
0.6567 |
Remote Similarity |
NPD7930 |
Approved |
0.6564 |
Remote Similarity |
NPD7435 |
Discontinued |
0.6561 |
Remote Similarity |
NPD7296 |
Approved |
0.6561 |
Remote Similarity |
NPD8651 |
Approved |
0.6558 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6558 |
Remote Similarity |
NPD5126 |
Approved |
0.6556 |
Remote Similarity |
NPD6671 |
Approved |
0.6552 |
Remote Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.6552 |
Remote Similarity |
NPD6801 |
Discontinued |
0.655 |
Remote Similarity |
NPD5403 |
Approved |
0.6545 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6543 |
Remote Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.6543 |
Remote Similarity |
NPD1558 |
Phase 1 |
0.6536 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6536 |
Remote Similarity |
NPD9545 |
Approved |
0.6536 |
Remote Similarity |
NPD3091 |
Approved |
0.6531 |
Remote Similarity |
NPD2684 |
Approved |
0.6527 |
Remote Similarity |
NPD3060 |
Approved |
0.6524 |
Remote Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.6524 |
Remote Similarity |
NPD4536 |
Approved |
0.6524 |
Remote Similarity |
NPD4538 |
Approved |
0.6524 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6522 |
Remote Similarity |
NPD7038 |
Approved |
0.6522 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6522 |
Remote Similarity |
NPD3764 |
Approved |
0.6522 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6522 |
Remote Similarity |
NPD7039 |
Approved |
0.6519 |
Remote Similarity |
NPD2797 |
Approved |
0.6514 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6514 |
Remote Similarity |
NPD5773 |
Approved |
0.6514 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6514
|
Remote Similarity |
NPD5772 |
Approved |